Enter your email address below and subscribe to our newsletter

Patient Education

Share your love

First patients dosed in JC02-88 study

(Image credit: ©Alernon77/AdobeStock) jCyte recently announced the dosing of the first patients enrolled in the JC02-88 study for the evaluation of famzeretcel (jCell; jCyte) for the treatment of retinitis pigmentosa (RP).1 Famzeretcel consists of allogeneic retinal progenitor cells (RPCs) administered…

Stay informed and not overwhelmed, subscribe now!